| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/23/2008 | US7427667 monoclonal; humanized; fragments; labeled |
| 09/23/2008 | US7427665 Chronic lymphocytic leukemia cell line |
| 09/23/2008 | US7427658 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 09/23/2008 | US7427639 β2-adrenergic receptor agonists |
| 09/23/2008 | US7427596 Having mutations in the Kinase domain region (KDR) and/or the FMS-like Tyrosine-Kinase region (FLT-1), said variants exhibiting modified binding characteristics at said regions compared with native VEGF; stimulates vasculogenesis or angiogenesis; wound healing |
| 09/23/2008 | US7427513 Heating solution of metal dissolved in reducing agent to produce the metallic colloid, modifying the metallic colloid by attaching the Raman enhancing organic molecule such as thiomalic acid, L-cysteine diethyl ester, S-carboxymethyl-L-cysteine, cystamine, or meso-2,3-dimercaptosuccinic acid |
| 09/23/2008 | US7427512 for the manipulation of colloidal particulates and biomolecules at the interface between an insulating electrode such as silicon oxide and an electrolyte solution; for fabrication of surface-mounted optical components; drug screening |
| 09/23/2008 | US7427511 sample receiving member disposed to cover the label holding member and in contact with the chromatographic membrane, and the chromatographic membrane is spaced apart from the label holding member |
| 09/23/2008 | US7427507 Specifically tigecycline; crushing the bone, adding a stabilizing agent, homogenizing in an extraction solvent to obtain a homogenous suspension, and analyzing the suspension supernatant; stabilizing agent is preferably a reductant that prevents oxidation of the antibiotic; ascorbic acid |
| 09/23/2008 | US7427506 High throughput property testing of olefin copolymers using rheological determinations |
| 09/23/2008 | US7427505 Fecal occult blood testing device and method |
| 09/23/2008 | US7427504 analyzing formation fluid in earth formation surrounding a borehole includes storing analytical reagent in a reagent container in a fluids analyzer in a formation tester and moving the formation tester, including the reagent, downhole |
| 09/23/2008 | US7427498 Composition, methods and reagents for the synthesis of a soluble form of human PHEX |
| 09/23/2008 | US7427497 In vitro metabolic engineering on microscale devices |
| 09/23/2008 | US7427495 Enhancing or inhibiting apoptosis |
| 09/23/2008 | US7427491 Nanoparticles for optical sensors |
| 09/23/2008 | US7427490 Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| 09/23/2008 | US7427489 administering an agent that modulates BK channel activity; cyclic expression of a calcium dependent potassium channel (BK channel) correlates to locomotor activity and anticipates the sleep/wake cycle |
| 09/23/2008 | US7427488 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same |
| 09/23/2008 | US7427487 for the direct identification of candidate compounds such as receptor agonists, inverse agonists, partial agonist or antagonist for use in graft rejection; inflammatory skin disease; inflammatory bowel disease; allergic inflammation, pulmonary inflammation, inflammatory demyelinating neuropathy |
| 09/23/2008 | US7427486 Mullerian inhibiting substance levels and ovarian response |
| 09/23/2008 | US7427485 Method for classification of anti-psychotic drugs |
| 09/23/2008 | US7427483 amplification of the 42-kDa C-terminal region of the MSP1 gene by using the PCR technique in the presence of digoxigenin-11-dUTP and the synthesis of the specific biotin labeled nucleotide probes directed to the 42-kDa C-terminal region of the MSP1 gene |
| 09/23/2008 | US7427476 Using hypermethylation of T-type calcium channel(CACNA1G) gene sequences as diagnostic indicator of cell proliferative disorders; calcium channel blocker and cancer treatment |
| 09/23/2008 | US7427468 Anti-TSG101 antibodies and their uses for treatment of viral infections |
| 09/23/2008 | US7427403 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents |
| 09/23/2008 | US7427400 Administering antibody or a fragment thereof that binds to a human homolog of frizzled, to inhibit the proliferation of cancer cells |
| 09/23/2008 | US7427394 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 09/23/2008 | US7427392 Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau |
| 09/23/2008 | US7427380 integrated sample handling and detection system; simultaneous preparation and performance of multiple assays of rapidly occurring, transient phenomena in individual wells of a test plate; imaging of assays with sensitivity and a high degree of accuracy continuously; data analysis and storage |
| 09/23/2008 | US7427378 Analysis method and apparatus for sulfur component using ultraviolet fluorescence |
| 09/23/2008 | US7427377 Analyte concentration detection devices and methods |
| 09/23/2008 | US7427376 Sample analyzer and its components |
| 09/23/2008 | US7426850 Outer casing for gas sensor |
| 09/23/2008 | CA2502491C A digital imaging system for assays in well plates, gels and blots |
| 09/23/2008 | CA2401224C System for keeping calender rolls of a paper machine clean |
| 09/23/2008 | CA2309838C Haptoglobin assay |
| 09/23/2008 | CA2259940C High-affinity interleukin-4 muteins |
| 09/23/2008 | CA2227281C Determination of an analyte in a liquid medium |
| 09/23/2008 | CA2186004C Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
| 09/23/2008 | CA2169852C Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 09/23/2008 | CA2143125C Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 09/23/2008 | CA2139430C Polypeptides having serotoninergie activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof |
| 09/20/2008 | CA2626349A1 Systems and methods for pattern recognition in diabetes management |
| 09/18/2008 | WO2008112868A1 Automated colorimetric polysaccharide assays |
| 09/18/2008 | WO2008112840A2 Novel composition and methods for the treatment of immune related diseases |
| 09/18/2008 | WO2008112801A1 Macular degeneration |
| 09/18/2008 | WO2008112798A1 Treating pre-eclempsia and cardiovascular diseases |
| 09/18/2008 | WO2008112772A2 Gene expression in peripheral blood mononuclear cells from children with diabetes |
| 09/18/2008 | WO2008112749A1 Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase |
| 09/18/2008 | WO2008112680A2 Global polyclonal antibodies, process for depleting commonly shared proteins by same, devices using same |
| 09/18/2008 | WO2008112626A1 Non-linear rotation rates of remotely driven particles and uses thereof |
| 09/18/2008 | WO2008112514A1 He4 monoclonal antibodies and methods for their use |
| 09/18/2008 | WO2008112424A1 Assessing heart failure |
| 09/18/2008 | WO2008112307A2 Toll-like receptor 4 deficiency and downstream effectors cause pulmonary emphysema |
| 09/18/2008 | WO2008112232A2 Methods for monitoring gamma secretase inhibition in vivo |
| 09/18/2008 | WO2008112195A1 Methods for identifying agents and their use for the prevention or stabilization of fibrosis |
| 09/18/2008 | WO2008112193A1 Prognostic, diagnostic, and cancer therapeutic uses of fanci and fanci modulating agents |
| 09/18/2008 | WO2008112008A2 Sensor proteins and assay methods |
| 09/18/2008 | WO2008111996A2 Muc1-ikb kinase complexes and their activities |
| 09/18/2008 | WO2008111981A1 Compositions, systems, and methods for preservation of macromolecules |
| 09/18/2008 | WO2008111938A1 Test-sensor cartridge |
| 09/18/2008 | WO2008111937A1 Analyte-testing instruments |
| 09/18/2008 | WO2008111935A1 Meter adapted to simultaneously display the number of high, low and total test results |
| 09/18/2008 | WO2008111933A1 Single-sensor meter system with no sensor handling and method of using the same |
| 09/18/2008 | WO2008111916A1 Glycosphingolipid-aided intracellular delivery of cargo molecules |
| 09/18/2008 | WO2008111855A1 Biosensor, surface coating and assay |
| 09/18/2008 | WO2008111831A1 Method for testing a compound as an allergen |
| 09/18/2008 | WO2008111742A1 Electrochemical biosensor measuring system |
| 09/18/2008 | WO2008111736A1 Drug monitoring order system and method thereof |
| 09/18/2008 | WO2008111666A1 Method of measuring number of nonmetallic inclusions and mold for taking of casting sample for use therein |
| 09/18/2008 | WO2008111634A1 Biomarker specific to brain/nerve or specific to neuronal differentiation |
| 09/18/2008 | WO2008111599A1 Method for detecting biologically relevant substance |
| 09/18/2008 | WO2008111527A1 Method of evaluating foam-holding property of fermented malt drink and marker for evaluating foam-holding |
| 09/18/2008 | WO2008111520A1 Gene related to life extension and use thereof |
| 09/18/2008 | WO2008111485A1 Compound having structure derived from mononucleoside or mononucleotide, nucleic acid, labeling substance, and method and kit for detection of nucleic acid |
| 09/18/2008 | WO2008111466A1 Method for examination of activity of anti-cancer agent employing reduction in expression level of gene as measure |
| 09/18/2008 | WO2008111464A1 Method for examination of action of anti-cancer agent utilizing splicing defect as measure |
| 09/18/2008 | WO2008111343A1 Method for analysis of epitope |
| 09/18/2008 | WO2008111293A1 Rare-earth complex and use thereof |
| 09/18/2008 | WO2008111281A1 Determination method for allergic disease |
| 09/18/2008 | WO2008111095A1 Reagent for detection of analyte and processes thereof |
| 09/18/2008 | WO2008111088A2 Jasmonate based assays for identifying compounds that selectively inhibit mitochondrial bound hexokinases |
| 09/18/2008 | WO2008111063A2 Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions |
| 09/18/2008 | WO2008111047A1 Micro-nails for use in electrical interaction with cells |
| 09/18/2008 | WO2008111013A2 Bead assisted analyte detection |
| 09/18/2008 | WO2008110781A1 Lateral flow assay and apparatus |
| 09/18/2008 | WO2008110777A2 Modulators of vegf splicing as pro- and anti-angiogenic agents |
| 09/18/2008 | WO2008110667A1 Web measurement |
| 09/18/2008 | WO2008110624A2 Sirna-mediated silencing of genes for treating chemotherapeutic drug-resistant epithelial tumors |
| 09/18/2008 | WO2008110593A2 Method and markers for the diagnosis of renal diseases |
| 09/18/2008 | WO2008110581A2 Mass spectrometric quantitation |
| 09/18/2008 | WO2008110570A1 Method to study proliferation of endothelial progenitor cells and the potential influence of compounds on their proliferation behaviour |
| 09/18/2008 | WO2008110569A1 Method for determination of immunomodulatory effect |
| 09/18/2008 | WO2008110392A2 Biopsy device for the in vivo enrichment of tissue, cells, or analytes |
| 09/18/2008 | WO2008110375A1 Device and method for the online control of drinking water on human tolerance within a drinking water supply network |
| 09/18/2008 | WO2008110373A1 Method of providing human tumor-specific antibodies |
| 09/18/2008 | WO2008110372A1 Monoclonal human tumor-specific antibody |
| 09/18/2008 | WO2008110356A2 Protein pi 16 secreted from the heart and uses thereof |
| 09/18/2008 | WO2008110285A1 Fluorescence-based assay for detecting compounds for modulating the sodium-calcium exchanger (ncx) in “forward mode” |